People Background Check
Find People:

Michael E Dayton12 Greystone Ln, Erial, NJ 08081

Get Report
Known as:
M Dayton Michael A Dayton Michael E Coc Dayton Mike Dayton

Michael Dayton Phones & Addresses

12 Greystone Ln, Sicklerville, NJ 08081 (609) 790-5116

Saint Petersburg, FL

Work

Company: Sipe steel rule die, inc Jan 2003 Position: Project manager/cost estimator

Education

School / High School: University of South Florida- Tampa, FL Specialities: Bachelor of Arts

Mentions for Michael E Dayton

Career records & work history

Medicine Doctors

Michael W. Dayton

Specialties:
Family Medicine
Work:
Michael W Dayton MD
7131 N 11 St STE 102, Fresno, CA 93720
(559) 435-6120 (phone) (559) 435-9882 (fax)
Education:
Medical School
Creighton University School of Medicine
Graduated: 1974
Procedures:
Arthrocentesis, Destruction of Benign/Premalignant Skin Lesions, Sigmoidoscopy, Vaccine Administration
Conditions:
Acute Sinusitis, Allergic Rhinitis, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Abnormal Vaginal Bleeding, Acne, Acute Bronchitis, Acute Pharyngitis, Acute Upper Respiratory Tract Infections, Anemia, Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Attention Deficit Disorder (ADD), Benign Paroxysmal Positional Vertigo, Benign Prostatic Hypertrophy, Bronchial Asthma, Calculus of the Urinary System, Chronic Renal Disease, Chronic Sinusitis, Constipation, Contact Dermatitis, Depressive Disorders, Dermatitis, Epilepsy, Erectile Dysfunction (ED), Fractures, Dislocations, Derangement, and Sprains, Gastroesophageal Reflux Disease (GERD), Gout, Heart Failure, Herpes Simplex, Herpes Zoster, Hypertension (HTN), Hypothyroidism, Inguinal Hernia, Irritable Bowel Syndrome (IBS), Lateral Epicondylitis, Menopausal and Postmenopausal Disorders, Metabolic Syndrome, Migraine Headache, Osteoarthritis, Osteoporosis, Overweight and Obesity, Peripheral Nerve Disorders, Restless Leg Syndrome, Rosacea, Skin and Subcutaneous Infections, Skin Cancer, Tension Headache, Tinea Unguium, Urinary Incontinence
Languages:
English, Spanish
Description:
Dr. Dayton graduated from the Creighton University School of Medicine in 1974. He works in Fresno, CA and specializes in Family Medicine.

Michael R. Dayton

Specialties:
Orthopaedic Surgery
Work:
University Colorado Hospital Orthopedics Anschutz
1635 Aurora Ct FL 4, Aurora, CO 80045
(720) 848-1900 (phone)
Education:
Medical School
University of Utah School of Medicine
Graduated: 1997
Procedures:
Arthrocentesis, Hip Replacement, Knee Arthroscopy, Knee Replacement, Occupational Therapy Evaluation, Hip/Femur Fractures and Dislocations, Joint Arthroscopy, Lower Leg/Ankle Fractures and Dislocations, Shoulder Surgery, Wound Care
Conditions:
Osteoarthritis, Fractures, Dislocations, Derangement, and Sprains, Internal Derangement of Knee Cartilage, Sciatica
Languages:
English, Spanish
Description:
Dr. Dayton graduated from the University of Utah School of Medicine in 1997. He works in Aurora, CO and specializes in Orthopaedic Surgery. Dr. Dayton is affiliated with University Of Colorado Hospital.

Michael Dayton resumes & CV records

Resumes

Michael Dayton Photo 38

Michael Dayton - Auburn, IN

Work:
Sipe Steel Rule Die, Inc Jan 2003 to 2000
Project Manager/Cost Estimator Custom Lights, Inc./Garrett Products, Inc 1999 to 2003
Project/Product Manager Custom Lights, Inc./Garrett Products, Inc. - Garrett, IN 1995 to 1999
Production Supervisor
Education:
University of South Florida - Tampa, FL
Bachelor of Arts

Publications & IP owners

Us Patents

Minimally Invasive Bioactivated Endoprosthesis For Vessel Repair

US Patent:
5449382, Sep 12, 1995
Filed:
Mar 2, 1994
Appl. No.:
8/204947
Inventors:
Michael P. Dayton - Tampa FL
International Classification:
A61F 206
US Classification:
623 1
Abstract:
A minimally invasive bioactivated endoprosthesis device for vessel repair. The device comprises a stent which is formed from metal or polymers into a predetermined shape which includes a plurality of holes patterned with a desired size, shape and number to provide a desired bending modulus. The stent is then coated with a polymer or is formed from a polymer which contains a bioactive substance which achieves an equilibrium with the surrounding body tissues or fluids, with the equilibrium being controlled by charge distribution, concentration and molecular weight of the bioactive substance in relation to the pore size of the polymeric carrier for controlled prolonged release of said bioactive substance. The bioactive substance may be selected from the group of heparin, hirudin, prostacyclenes and analogs thereof, antithrombogenic agents, steroids, ibuprofen, antimicrobials, antibiotics, tissue plasma activators, rifamicin, monoclonal antibodies, snake venom protein by-products, antifibrosis agents, cyclosporine and mixtures of these bioactive substances for simultaneous multiple treatments. The stent itself may take several distinct configurations, all of which have a predetermined biasing force acting on the diameter of the stent.

Minimally Invasive Bioactivated Endoprosthesis For Vessel Repair

US Patent:
5578075, Nov 26, 1996
Filed:
Jun 1, 1995
Appl. No.:
8/457850
Inventors:
Michael P. Dayton - Tampa FL
International Classification:
A61F 206
US Classification:
623 1
Abstract:
A minimally invasive bioactivated endoprosthesis device for vessel repair. The device comprises a stent which is formed from metal or polymers into a predetermined shape which may include a plurality of holes patterned with a desired size, shape and number. The stent is then coated with a polymer or is formed from a polymer which contains a bioactive substance which achieves an equilibrium with the surrounding body tissues or fluids, with the equilibrium being controlled by charge distribution, concentration and molecular weight of the bioactive substance in relation to the pore size of the polymeric carrier for controlled prolonged release of said bioactive substance. The bioactive substance may be selected from the group of heparin, hirudin, prostacyclenes and analogs thereof, antithrombogenic agents, steroids, ibuprofen, antimicrobials, antibiotics, tissue plasma activators, rifamicin, monoclonal antibodies, snake venom protein by-products, antifibrosis agents, hyaluronte, cyclosporine and mixtures of these bioactive substances for simultaneous multiple treatments. The stent itself may take several distinct configurations. Preferred is a stent which comprises a substructure selected from flat sheets, flat sheets having holes therein, meshes and stent frames having a sheath thereon, and the substructure is coated with a polymer embedded with a bioactive substance.

Synthetic Reconstructive Implant Device

US Patent:
5344451, Sep 6, 1994
Filed:
May 5, 1993
Appl. No.:
8/059178
Inventors:
Michael P. Dayton - Tampa FL
International Classification:
A61F 212
US Classification:
23 8
Abstract:
A synthetic reconstructive surgical implant device and method for making the same in which the device is suitable for implanting in a human. The device includes a sealed prosthesis envelope having a predetermined shape when filled, with the envelope being formed from an elastic polymer having a microporous structure with a texturized or non-texturized surface, such as silicone, polyurethane, polyvinylalcohol polyethylene, polyesters, hydrogels, tetrafluroethylene and polytetrafluroethylene, fluorosilicone and mixtures thereof. The envelope is filled with a biocompatible viscoelastic material in an amount sufficient to provide the predetermined shape. The biocompatible viscoelastic material is a sterile, non-pyrogenic solution which, in a preferred embodiment may be selected from salts of chondrotin sulfate, salts of hyaluronate, hydroxyproplymethylcellulose and mixtures thereof. In another preferred embodiment, the device includes a bioactive substance admixed in the polymer for elution from the microporous structure of the envelope after implantation. The bioactive substance may be selected from the group of heparin, prostacyclenes, steroids, ibuprofen, antimicrobials, antibiotics, tissue plasma activators, monoclonal antibodies, snake venom protein by-products, antifibrosis agents, cyclosporine and mixtures thereof.

Possible Relatives

Dana L Dayton  Diana R Dayton  Donald A Dayton  Elizabeth A Dayton  Ellen J Dayton  Emily I Dayton  Eric D Dayton  Michael A Last  Michael D Stanaland  Michael Stanberry 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.